Intraoperative radiation therapy of breast cancer: Evidence-based status

被引：0
作者：
Bottke D. [1 ]
Scholz C. [2 ]
Bottke R. [1 ]
De Gregorio N. [2 ]
Janni W. [2 ]
Wiegel T. [1 ]
机构：
[1] Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Ulm, 89081 Ulm
[2] Frauenklinik, Universitätsklinikum Ulm
来源：
Der Gynäkologe | 2013年 / 46卷 / 8期
关键词：
Breast-conserving therapy; Irradiation; Percutaneous; Postoperative; Randomized study;
D O I：
10.1007/s00129-013-3220-0
中图分类号：
学科分类号：
摘要：
The standard technique of postoperative radiotherapy after breast-conserving surgery is percutaneous irradiation of the entire breast which is usually followed by a tumor bed boost. Due to the increased detection of small breast carcinomas by mammographic screening, it is necessary to consider a possible change of the existing therapeutic practice. Since the majority of local recurrences occur close to the former tumor bed, the question arises whether a sole tumor bed irradiation might be a therapeutic alternative to total breast irradiation. At present prospective and randomized studies investigate for which patients an intraoperative radiotherapy is sufficient as the sole irradiation method after previous surgery. Intraoperative radiotherapy as a boost preceding percutaneous whole-breast irradiation is already possible according to a relevant statement of the DEGRO. © 2013 Springer-Verlag Berlin Heidelberg.
引用
收藏
页码：581 / 584
页数：3
相关论文
共 17 条
  • [1] Fisher B., Anderson S., Bryant J., Et al., Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, pp. 1233-1241, (2002)
  • [2] Veronesi U., Cascinelli N., Mariani L., Et al., Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, pp. 1227-1232, (2002)
  • [3] Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials, N Engl J Med, 333, pp. 1444-1455, (1995)
  • [4] Clarke M., Collins R., Darby S., Et al., Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials, Lancet, 366, pp. 2087-2106, (2005)
  • [5] Bartelink H., Horiot J.C., Poortmans P.M., Et al., Impact of a higher radiation dose on local control and survuval in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial, J Clin Oncol, 25, pp. 3259-3265, (2007)
  • [6] Interdisziplinäre S3-Leitlinie für Die Diagnostik, Theapie und Nachsorge des Mammakarzinoms - Version 3.0, (2012)
  • [7] Sedlmayer F., Fastner G., Merz F., Et al., IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: Results of an ISIORT pooled analysis, Strahlenther Onkol, 183, pp. 32-34, (2007)
  • [8] Wenz F., Welzel G., Blank E., Et al., Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: The first 5 years of experience with a novel approach, Int J Radiat Oncol Biol Phys, 77, pp. 1309-1314, (2010)
  • [9] Vaidya J.S., Baum M., Tobias J.S., Et al., Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery, Int J Radiat Oncol Biol Phys, 81, pp. 1091-1097, (2011)
  • [10] Bentzen S.M., Agrawal R.K., Aird E.G., Et al., The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomized trial, Lancet, 371, pp. 1098-1107, (2008)
12